| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $48.6M | +96.2% |
| SG&A Expense | $19.0M | +71.7% |
| Operating Income | -$67.6M | -88.6% |
| Net Income | -$63.3M | -78.2% |
| EPS (Basic) | -$1.14 | -48.1% |
| EPS (Diluted) | -$1.14 | -48.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.5M | -91.1% |
| Short-term Investments | $303.9M | +255.4% |
| Current Assets | $335.1M | -13.1% |
| Total Assets | $341.1M | -12.7% |
| Current Liabilities | $10.8M | +104.0% |
| Total Liabilities | $13.8M | +64.1% |
| Stockholders' Equity | $327.3M | -14.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.3M | -74.7% |
| Capital Expenditures | $918K | -40.3% |
| Investing Cash Flow | -$221.0M | -312.0% |
| Financing Cash Flow | $235K | -99.9% |
| Free Cash Flow | -$52.2M | -69.0% |